TNS Healthcare Launches Call Assessment Tool

In the US, TNS Healthcare has introduced a new service to help pharmaceutical and biotech companies measure the effectiveness of their own and competitive sales calls.

DetailMed helps clients pinpoint where their reps are 'on' or 'off' message and determine the impact this has on prescribing intent, evaluate brand awareness and usage, understand brand commitment, and assess how their reps' performance compares with the competition.

The new system also measures share of voice, as well as message recall and effectiveness, while providing norms that allow companies to benchmark their results. Real-time feedback is delivered through an online dashboard which is custom-built to each customer's specific needs.

Currently the service covers the US and major European markets, and the firm is considering expansion into Asia-Pacific and Latin America. Users can choose the geographic level and frequency with which they want to view results, as well as the therapeutic classes and physicians they want covered. In addition, they can add proprietary questions and custom analytics to enrich their insights.

David Owen, Director TNS Healthcare explained: 'Local call assessment services could not give our customers what they needed to drive global brand success. With DetailMed, pharma companies finally have a solution that lets them measure message impact and call quality across countries - a strategic necessity for fully understanding and optimizing brand performance.'

In January, the division appointed Ceri Thomas to the new position of Executive Vice President of Global Accounts (www.mrweb.com/drno/news7875.htm ), Larry Olson as VP Practice Leader Payer Markets, and Dennis Callahan as VP Sales Force Effectiveness (www.mrweb.com/drno/news7782.htm ).

Web site: www.tnsglobal.com/healthcare .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.

• TNS (USA)
• All news